1Lai CJ, Terrauh NA. Antiviral therapy in patients with chronic hepatitis B and cirrhosis. Gastroenterol Clin N Am, 2004, 33 (3) : 629-654 被引量：1
2Trevisani F, Gastelli E, Foschi FG, et al. Impaired tuftsin activity in cirrhosis relationship with splenic function and dinical outcome. Gut,2002, 50 (5): 707-712 被引量：1
3Lau DT, Everhart, J, Kleiner DE, et al. Long - term follow- up of patients with chronic hepatitis B treat with interferon alfa. Gastroenterolngy, 1997, 113 (5): 1660-1667 被引量：1
4Hadiyannis SJ, Papatheodoridis GV, Vassilopoulos D. Treatment of HBeAg - negative chronic hepatitis B. Semi Liver Dis, 2003, 23 (1) :81-88 被引量：1
5Merlep Trepo C. Therapeutic management of hepatitis B - related cirrhosis J Viral Hepat, 2001, 8 (6) : 391-399 被引量：1
6Brunetto MR, Oliveri F, Coco B, et al. Outcome of anti - HBe - positive chronic hepatitis B in slfa - interferon treat and untreat patients: a long- term cohort study. J Hepatol, 2002, 36 (2) : 263--270 被引量：1
7Lampertico P, Del Nimo E, Vigano M, et al. Long- term suppression of hepatitis B e antigen - negative chronic hepatitis B by - 24 mouth interferon therapy. Hepatology, 2003, 37 (4): 756-753 被引量：1
8Papatheodoridis GV, Mnnesis E, Hadziyannis SJ. The long - term outcrane of interferon alfa - treated and untreated patients with HBeAgnegative chronic hepatitis B.J Hepatol, 2001, 34 (2): 306-313 被引量：1
9Zavaglia C, Airoldi A, Pimello G, et al. Antivirotic therapy of HBV -and HCV-induced liver cirrhosis. J. Clin Gastroenterol, 2000, 30(3): 234-241 被引量：1
10Dienstag JL, Goldin RD, Heathcote EJ, et al. Histological outcome during long-term lamivudine therapy. Gastroenterology, 2003, 124(1):105-117 被引量：1
